# Protalix BioTherapeutics, Inc.: Form 8-K, filed Jan 13, 2014

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2014-01-13
- Accepted by EDGAR: Jan 13, 2014, 07:35 ET
- Period: 2014-01-13
- Accession: 0001144204-14-001804
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420414001804/v365223_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420414001804/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420414001804/v365223_8-k.htm

Filed Jan 13, 2014.
Source: SEC EDGAR, the filing index for accession 0001144204-14-001804. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
